Patents Assigned to Callion Pharma, LLC
  • Patent number: 11229230
    Abstract: Provided herein are antioxidant-enriched multivitamin compositions comprising vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, thiamin, riboflavin, niacin, vitamin B6, folic acid, vitamin B 12, biotin, pantothenic acid, zinc, selenium, coenzyme Q10, lutein, lycopene, and zeaxanthin for the treatment of fat malabsorption diseases such as cystic fibrosis. Also provided are methods of treating vitamin and micronutrient deficiencies in subjects suffering from cystic fibrosis by administering an antioxidant-enriched multivitamin composition.
    Type: Grant
    Filed: October 24, 2017
    Date of Patent: January 25, 2022
    Assignee: Callion Pharma, LLC
    Inventor: Konstantinos Andreas Papas
  • Patent number: 10688107
    Abstract: A scalable vitamin composition unit dosage adapted to treat a fat-soluble vitamin deficiency in a subject is provided herein, the unit dosage consisting essentially of vitamin D, vitamin E, vitamin K, and vitamin A, wherein the unit dosage is substantially free of additional vitamins and wherein the unit dosage is scalable based on the weight, age, and condition of a subject without inducing toxic effects. Also provided are methods of treating a fat-soluble vitamin deficiency in a subject in need thereof by administering to the subject an effective amount of a unit dosage as described herein.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: June 23, 2020
    Assignee: Callion Pharma, LLC
    Inventor: Konstantinos Andreas Papas
  • Publication number: 20190281876
    Abstract: Provided herein are antioxidant-enriched multivitamin compositions comprising vitamin A, vitamin C, vitamin D, vitamin E, vitamin K, thiamin, riboflavin, niacin, vitamin B6, folic acid, vitamin B 12, biotin, pantothenic acid, zinc, selenium, coenzyme Q10, lutein, lycopene, and zeaxanthin for the treatment of fat malabsorption diseases such as cystic fibrosis. Also provided are methods of treating vitamin and micronutrient deficiencies in subjects suffering from cystic fibrosis by administering an antioxidant-enriched multivitamin composition.
    Type: Application
    Filed: October 24, 2017
    Publication date: September 19, 2019
    Applicant: Callion Pharma, LLC
    Inventor: Konstantinos Andreas Papas